Comparative Assessment of VTE and Other Risks among Patients with Rheumatoid Arthritis treated with Baricitinib versus Tumor Necrosis Factor Inhibitors: A Multi-database Observational Cohort Study

First published 17/12/2020

Last updated 23/04/2024

EU PAS number:

EUPAS32271

Study

Finalised

Documents

Study protocol

Initial protocol

B023 05 Protocol(d)

English (856.46 KB - PDF)View document

Study results

Non interventional PASS B023 Final Study Report_Redacted_Part 1 of 6

English (2.11 MB - PDF)View document

Study report

Non interventional PASS B023 Final Study Report_Redacted_Part 2 of 6

English (9.51 MB - PDF)View document

Non interventional PASS B023 Final Study Report_Redacted_Part 3 of 6

English (6.11 MB - PDF)View document

Non interventional PASS B023 Final Study Report_Redacted_Part 4 of 6

English (9.5 MB - PDF)View document

Non interventional PASS B023 Final Study Report_Redacted_Part 5 of 6

English (9.5 MB - PDF)View document

Non interventional PASS B023 Final Study Report_Redacted_Part 6 of 6

English (4.27 MB - PDF)View document

Other information

Study, other information

Non interventional PASS B023 Final Study Report_Redacted_Part 6 of 6.pdf

English (4.27 MB - PDF)View document

Non interventional PASS B023 Final Study Report_Redacted_Part 5 of 6.pdf

English (9.5 MB - PDF)View document

Non interventional PASS B023 Final Study Report_Redacted_Part 4 of 6.pdf

English (9.5 MB - PDF)View document

Non interventional PASS B023 Final Study Report_Redacted_Part 3 of 6.pdf

English (6.11 MB - PDF)View document

ENCePP Seal

ENCePP Seal documents

Secondary tabs